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Introduction: Despite informal caregivers’ integral role
in supporting people affected by disease or disability,
economic evaluations often ignore the costs and
benefits experienced by this group, especially in the
palliative setting. The purpose of this systematic review
is to identify preference-based instruments for
measuring care-related outcomes and provide guidance
on the selection of instrument in palliative care
economic evaluations.
Methods and analysis: A comprehensive search of
the literature will be conducted from database inception
(ASSIA; CINAHL; Cochrane library including DARE,
NHS EED, HTA; Econlit; Embase; PsychINFO; PubMed).
Published peer-reviewed, English-language articles
reporting preference-based instruments for measuring
care-related outcomes in any clinical area will be
included. One researcher will complete the searches
and screen the results for potentially eligible studies.
A randomly selected subset of 10% citations will be
independently screened by two researchers. Any
disagreement will be resolved by consensus among the
research team. Subsequently, a supplementary search
will identify studies detailing the development,
valuation, validation and application of the identified
instruments. The degree of suitability of the
instruments for palliative economic evaluations will be
assessed using criteria in the International Society for
Quality of Life Research minimum standards for
patient-reported outcome measures, the checklist for
reporting valuation studies of multiattribute utility-
based instruments and information on the development
of the instrument in the palliative setting. A narrative
summary of the included studies and instruments will
be provided; similarities and differences will be
described and possible reasons for variations explored.
Recommendations for practice on selection of
instruments in palliative care economic analyses will be
provided.
Ethics and dissemination: This is a planned
systematic review of published literature. Therefore,
ethics approval to conduct this research is not
required. Findings will be presented at leading palliative
care and health economic conferences and published
in a peer-reviewed journal.
Trial registration number: CRD42016034188.
INTRODUCTION
Societies increasingly, and implicitly, rely on
informal caregivers’ willingness to take on,
maintain and repeat their caring role.1–3
Hence, informal caregivers are integral to
healthcare service provision, particularly in
clinical areas such as mental health, disabil-
ity, dementia, cardiovascular disease, cancer,
and palliative and end-of-life care.4–7 In this
context, an informal caregiver is a person
who provides regular, ongoing assistance to a
person with progressive illness usually
without receiving payment for the care they
provide and could include family members,
friends or neighbours.8
Strengths and limitations of this study
▪ The planned systematic review will inform guid-
ance on the selection of informal caregiver
outcome measures for economic evaluations of
palliative care, promoting the inclusion of infor-
mal caregiver costs and benefits in economic
analyses.
▪ The systematic review protocol is reported
according to the recommendations of the
Preferred Reporting Items for Systematic Review
and Meta-Analysis Protocols (PRISMA-p) state-
ment and is registered with the International
Prospective Register of Systematic Reviews
(PROSPERO).
▪ The total number of preference-based instru-
ments measuring care-related outcomes may be
small, limiting the study findings.
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The WHO defines palliative care as, ‘an approach
that improves the quality of life (QOL) of patients and
their families facing the problem associated with life-
threatening illness, through the prevention and relief of
suffering by means of early identification and impec-
cable assessment and treatment of pain and other pro-
blems, physical, psychosocial and spiritual’.9 At the end
of life, annual contributions by informal caregivers have
been estimated at $A40 billion (£21 billion, $A1=£0.52, 4
March 2016) in Australia10 and between one-third and
one-fifth of overall costs (health, social, informal care
and out of pocket) in the UK and Canada, respect-
ively.11 12 Further, contributions by informal caregivers
in the USA have been estimated at over US$500 billion a
year (£367 billion, US$1=£0.71, 4 March 2016).13
Clearly, it is vital to consider the impacts on informal
caregivers of different models of service provision and
alternative health and social interventions when under-
taking health research and formulating health policy in
the palliative setting. Otherwise, cost shifting and exces-
sive burden on family and friends could threaten the
continued provision of this highly valued care.14
International, consensus-based, best practice guide-
lines on evaluating palliative and end-of-life care services
highlight the need to include informal caregiver costs
and benefits in economic evaluations.15 Broadly, eco-
nomic evaluations systematically compare the relative
costs and benefits of competing courses of action, pro-
viding information about how best to improve patient
and family outcomes within funding constraints.
Increasingly, these types of economic analyses are used
to inform clinical, funding and policy decisions.16–19
Costs and benefits are considered simultaneously to
evaluate how best to achieve value for money from
scarce resources.20 The most commonly reported
measure of benefit in economic evaluations generally is
the quality-adjusted life year (QALY).21 The QALY is the
sum of time spent in different quality-weighted health
states, where the quality-weights represent values or pre-
ferences for alternative health states.22 23 Often generic,
preference-based measures of health-related quality of
life (HrQOL) such as the EQ-5D24 are used to generate
these quality weights.23 Preference-based measures allow
attributes of health to be valued differently.25 For
example, an increase in mobility may be more highly
valued by patients than a reduction in pain.
However, such generic measures tend to focus on
health alone as the sole indicator of benefit. Other
aspects of healthcare such as factors relating to the pro-
vision of services or care-specific domains, such as
control, may also be valued.26 27 Consequently, eco-
nomic evaluations which use generic, preference-based
measures do not enable robust coverage of the impacts
of interventions in complex disease areas such as pallia-
tive care where multiple, diverse domains of effect are
valued.28 29 It is vital that instruments used to measure
the impact of interventions for economic evaluations are
sensitive to things that matter to the patient and family.
Otherwise, measures will be unresponsive to change,
leading to a suboptimal model of measurement and
valuation of the true benefits of palliative strategies and
misinformed decisions about where best to invest
limited public funds.30
Empirical evidence indicates that conclusions relating
to the cost-effectiveness of healthcare interventions can
alter substantially when care-related costs and outcomes
are included in economic evaluations.31 32 Despite this,
impacts on informal caregivers have relatively rarely
been considered in economic analyses, especially in pal-
liative and end-of-life care.14 31 33 This is due, in part, to
the difficulties associated with conducting research in
this context, particularly capturing and valuing caregiv-
ing effects.14
The number of economic evaluations in palliative and
end-of-life care has recently started to increase.34–39
Despite this, guidance is lacking on which instruments
can be used for measuring care-related outcomes in eco-
nomic analyses, hindering inclusion of informal care-
giver costs and benefits. Previous systematic reviews in
the palliative setting have yielded many different types of
instruments for capturing informal caregiver outcomes
in health services research such as bereavement,
burden, family functioning, mood, needs, QOL, satisfac-
tion with service delivery and social support.40–42
However, preceding reviews did not consider the specific
requirements of outcome measures in economic evalua-
tions and may not have identified all relevant literature.
Consequently, the aim of this systematic review is to iden-
tify, critically appraise and provide guidance on the
selection of preference-based instruments for measuring
care-related outcomes in palliative care economic
evaluations.
Review questions
This systematic review aims to address three related
research questions:
1. What preference-based instruments are available gen-
erally, that is, in any clinical setting, to measure
care-related outcomes?
2. How have preference-based instruments measuring
care-related outcomes been developed, valued, vali-
dated and applied across clinical, research and policy
settings?
3. Have preference-based instruments measuring
care-related outcomes been validated and valued in
the palliative setting, that is, have preference weights
been obtained from a representative sample of
people receiving palliative care?
METHODS
A structured, three-step approach will be taken for the
systematic review. First, all preference-based instruments
measuring care-related outcomes in economic evalua-
tions in any clinical setting will be identified. Based on
the reviewers’ knowledge of this field, the total number
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of preference-based instruments specifically developed
for palliative and end-of-life care is anticipated to be
small. Therefore, no restrictions regarding clinical area
will be applied at this stage. Second, a supplementary
search will be conducted to identify all studies reporting
details on the development and application of the iden-
tified instruments, with particular attention paid to psy-
chometric properties and valuation methods. Finally, the
degree of suitability of the instruments for economic evalua-
tions in the palliative care setting will be assessed by scoring
whether the domains or dimensions were developed using
input from informal caregivers of people receiving palliative
care and whether items from the International Society for
Quality of Life Research (ISOQOL)43 minimum standards
for patient-reported outcome measures and the checklist
for reporting valuation studies of multiattribute utility-based
instruments (CREATE)44 have been evaluated in this popu-
lation. Any protocol amendments will be documented by
the lead author in the systematic review study protocol. The
Flinders University Health Sciences Liaison librarian will be
available to the team for the conduct of the study and spe-
cifically will provide guidance on the search strings for each
database.
Eligibility criteria
Published, peer-reviewed, English-language articles
reporting preference-based instruments for measuring
care-related outcomes in any clinical area will be eligible
for inclusion in the first step of the systematic review.
Inclusion criteria:
▸ Studies including informal caregivers of adult patients
receiving palliative care;
▸ Studies reporting the development or application of
a preference-based instrument for measuring care-
related outcomes;
▸ Primary and secondary research directly related to
the topic, that is, there will be no restrictions regard-
ing research methods;
▸ All geographical, national and social settings;
Exclusion criteria:
▸ Studies where the informal caregiver is a child or
young adult or a paid caregiver, for example, health-
care professionals or paid in-home care workers;
▸ Informal caregivers of people receiving curative or
maintenance care;
▸ Studies describing non-preference based care-related
measures;
▸ Studies reporting generic (non-specific) preference-
based measures;
▸ Studies applying unidimensional measures;
▸ Non-English articles and those not peer reviewed,
including editorials, comment or discussion papers,
conference articles and the grey literature.
Search strategy
A comprehensive search of the literature will be con-
ducted from database inception to the date of the
search (ASSIA; CINAHL; Cochrane library including
DARE, NHS EED, HTA; Econlit; Embase; PsychINFO;
and PubMed) to identify relevant published studies
meeting the inclusion criteria. Keywords and MeSH
terms, derived from previously conducted systematic
reviews of informal caregiver outcome measurement
tools and preference-based instruments, include follow-
ing: caregiver, family, volunteer, instrument, question-
naire, outcome assessment, preference-based, utility and
care-related and the search will be adapted for each
database (figure 1). The reference lists of the included
articles will be reviewed for additional literature unidenti-
fied by the search (pearling). Searches will be restricted
to English language only. Search results and retrieved
references will be deposited into Thomson Reuters
EndNote V. X7.1 (2014) libraries and this software will be
used to manage records throughout the review.
Selection process
First, the titles and abstracts will be reviewed by the lead
investigator who has over 10 years’ experience in con-
ducting systematic reviews to assess eligibility for inclu-
sion in the review. Full text articles will be retrieved
when the abstract contains insufficient information. If
necessary, corresponding authors will be contacted to
ascertain whether studies meet the inclusion criteria.
Second, the full text articles of potentially eligible
studies will be retrieved and independently assessed
from the first selection process, for inclusion in the
review. A randomly selected subset of citations (10%)
will be independently screened by two other members
of the research team. Agreement between the reviewers
will be assessed using the Kappa statistic to determine if
further duplicate reviewing is required.45 If the inter-
rater reliability is <0.8, that is, strong agreement,45 an
additional subset of citations (25%) will be independ-
ently screened. If the inter-rater reliability is still <0.8, all
remaining citations will be independently screened. Any
disagreements between reviewers will be resolved by con-
sensus among the research team.
Following identification of preference-based instru-
ments measuring care-related outcomes, a second com-
prehensive search of the literature using the same
databases will be conducted to identify studies reporting
details on the development, valuation, measurement
properties and application of the identified instruments
across clinical, research and policy settings. Keywords
and MeSH terms will include following: the name of the
instrument, ‘caregiver’, ‘valuation’ and ‘psychometric’.
Published, peer-reviewed, English-language articles report-
ing preference-based, care-related instrument develop-
ment, valuation, measurement properties and application
will be included. The same selection process will be
followed as detailed above to identify included articles.
As the total number of preference-based instruments
measuring care-related outcomes is anticipated to be
small, based on the reviewers’ knowledge of this field,
there will be no restrictions in terms of setting or study
quality assessment during the screening process.
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Data collection
A table will be created in Microsoft Office Excel 2010 to
extract data from the included studies, summarise the
evidence and inform assessment of the suitability of the
preference-based instruments for measuring care-related
outcomes in palliative care. This software will be used to
manage data throughout the review. The form will be
piloted with three of the included articles and updated
accordingly. Extracted information will include follow-
ing: study features (publication date, country of origin,
sample size, setting (clinical, research, policy), type of
study, study population, clinical area); instrument
description (name of instrument, information about the
instrument including domains or dimensions, number
of items, description of the items and response format,
administration method, ie, self-report, clinician adminis-
tered, other or unknown, conceptual and measurement
model, translation of the instrument, patient and investi-
gator burden); psychometric properties (content validity,
construct validity, reliability, responsiveness, floor or
ceiling effects, acceptability and feasibility); and valu-
ation (health states valued, preference elicitation tech-
nique, source for preference weights, modelling,
interpretability of scores and scoring algorithm). Two
reviewers will extract data independently (NM; RH).
Where there is ambiguity, input will be sought from a
third reviewer. Any disagreements between reviewers will
be resolved by consensus among the research team.
Two reviewers will independently assess the suitability
of the preference-based instruments for measuring out-
comes in palliative care using the ISOQOL, minimum
standards for patient-reported outcome measures
(conceptual and measurement model, reliability,
content validity, construct validity, responsiveness, inter-
pretability of scores, translation of measure, patient and
investigator burden),43 and the CREATE checklist
(descriptive system, health states values, sampling, pref-
erence data collection, study sample, modelling, scoring
algorithm).44 The ISOQOL minimum standards were
chosen as these standards were developed from a system-
atic review of published and unpublished guidance on
patient-reported outcome measures, including the
COnsensus-based Standards for the selection of health
Measurement Instruments (COSMIN).46 To the authors’
knowledge, the CREATE checklist is the only published
guidance on what key components should be reported
in a valuation study.44 Information on how the contents
of the instruments were developed, psychometric prop-
erties and valuation will be used to assess the suitability
of the instruments for the palliative setting; instruments
will be scored on whether the domains or dimensions
were developed using input from informal caregivers of
people receiving palliative care (yes/no) and whether
each of the reporting checklist items has been evaluated
for this population (if yes, then a score of one will be
allocated) and a total score calculated. Any discrepan-
cies will be identified and resolved by consensus among
the research team.
Data synthesis
A narrative summary of the included studies and instru-
ments will be provided in accordance with recent guid-
ance from the Cochrane Collaboration.47 Four tables
summarising the main features of the included studies,
Figure 1 EMBASE draft search
strategy.
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instrument descriptions, psychometric properties and
valuation will be presented (see ‘Data collection’).48
Using these data, similarities and differences between
the instruments will be described, including their suit-
ability for measuring care-related outcomes in palliative
care and possible reasons for variations between instru-
ments will be explored, for example, variability in study
populations and method of content development.
Recommendations for practice on selection of instru-
ments for measuring care-related outcomes in palliative
care economic analyses will be provided.
As the total number of preference-based instruments
measuring care-related outcomes is anticipated to be
small, to minimise reporting bias, the relevant develop-
ment groups will be contacted to make sure no crucial
information or developments have been missed.
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published in a peer-reviewed journal.
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